[Federal Register Volume 71, Number 141 (Monday, July 24, 2006)]
[Notices]
[Pages 41838-41839]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-11691]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 26, 2006, Sigma 
Aldrich Research BioChemicals, Inc., 1-3 Strathmore Road, Natick, 
Massachusetts 01760, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed in 
Schedules I and II:

------------------------------------------------------------------------
                       Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235).................................  I
Methcathinone (1237).............................  I
Aminorex (1585)..................................  I
Alpha-ethyltryptamine (7249).....................  I

[[Page 41839]]

 
Lysergic acid diethylamide (7315)................  I
Tetrahydrocannabinols (7370).....................  I
4-Bromo-2, 5-dimethoxy-amphetamine (7391)........  I
4-Bromo-2, 5-dimethoxyphenethylamine (7392)......  I
2, 5-Dimethoxyamphetamine (7396).................  I
3,4-Methylenedioxyamphetamine (7400).............  I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)...  I
3,4-Methylenedioxy-N-ethylamphetamine (7404).....  I
3,4-Methylenedioxymethamphetamine (MDMA) (7405)..  I
1-[1-2-Thienyl) cyclohexyl]phetamine (TCP) (7470)  I
1-Benzylpiperazine (BZP) (7493)..................  I
Heroin (9200)....................................  I
Normorphine (9313)...............................  I
Amphetamine (1100)...............................  II
Methamphetamine (1105)...........................  II
Nabilone (7379)..................................  II
1-Phenylcyclohexylamine (7460)...................  II
Phencyclidine (7471).............................  II
Cocaine (9041)...................................  II
Codeine (9050)...................................  II
Diprenorphine (9058).............................  II
Ecgonine (9180)..................................  II
Levomethorphan (9210)............................  II
Levorphanol (9220)...............................  II
Meperidine (9230)................................  II
Metazocine (9240)................................  II
Methadone (9250).................................  II
Morphine (9300)..................................  II
Thebaine (9333)..................................  II
Levo-alphacetylmethadol (9648)...................  II
Carfentanil (9743)...............................  II
Fentanyl (9801)..................................  II
------------------------------------------------------------------------

    The company plans to manufacture reference standards.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than September 22, 2006.

     Dated: July 10, 2006.
 Joseph T. Rannazzisi,
 Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-11691 Filed 7-21-06; 8:45 am]
BILLING CODE 4410-09-P